Stock Research: Champions Oncology

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Champions Oncology

NasdaqCM:CSBR US15870P3073
86
  • Value
    89
  • Growth
    35
  • Safety
    Safety
    27
  • Combined
    60
  • Sentiment
    96
  • 360° View
    360° View
    86
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Champions Oncology, Inc. is a preclinical and clinical research services provider specializing in oncology drug development. The company offers advanced technology solutions and products for personalized oncology drug development. It operates in the biotechnology and pharmaceutical industries. In the last fiscal year, the company had a market cap of $108 million, profits of $21 million, and revenue of $50 million, with 210 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 86 (better than 86% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Champions Oncology are very positive. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Champions Oncology. The consolidated Sentiment Rank has a good rank of 96, which means that professional investors are more optimistic about the stock than for 96% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 89 or better than 89% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 27, meaning that the share price of Champions Oncology is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 35. ...read more

more
Index
Moonshot Tech
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
27 10 42 37
Growth
35 97 25 61
Safety
Safety
89 1 100 100
Sentiment
96 72 18 25
360° View
360° View
86 54 11 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
68 71 3 31
Opinions Change
50 50 95 9
Pro Holdings
n/a 58 1 43
Market Pulse
90 52 55 94
Sentiment
96 72 18 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
27 10 42 37
Growth
35 97 25 61
Safety Safety
89 1 100 100
Combined
60 14 23 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
31 23 1 24
Price vs. Earnings (P/E)
85 64 87 93
Price vs. Book (P/B)
6 1 1 1
Dividend Yield
1 1 1 1
Value
27 10 42 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
61 63 48 43
Profit Growth
9 98 21 98
Capital Growth
13 34 25 29
Stock Returns
81 91 61 43
Growth
35 97 25 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
71 46 100 100
Refinancing
11 6 1 7
Liquidity
98 8 80 80
Safety Safety
89 1 100 100

Similar Stocks

Discover high‑ranked alternatives to Champions Oncology and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

PriceSmart

NasdaqGS:PSMT
Country: USA
Industry: Hypermarkets, Super Centers
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.